NASDAQ:LMNX Defiance Daily Target 2X Long LMND ETF (LMNX) Price, Holdings, & News $13.15 0.00 (0.00%) As of 05/22/2026 03:56 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock About Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LMNX alerts:Sign Up Key Stats Today's Range$13.02▼$14.0050-Day Range$11.01▼$22.4152-Week Range$10.81▼$55.00Volume15,462 shsAverage Volume46,254 shsMarket Capitalization$4.34 millionAssets Under Management$6.32 millionDividend Yield3.04%Net Expense Ratio1.31%Aggregate RatingN/A ETF Overview Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas. Read More Defiance Daily Target 2X Long LMND ETF ExpensesTypeLMNXSingle Stock ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee1.29%0.96%0.57%0.54%0.53%Other Expenses0.02%0.65%0.55%0.52%0.55%Total Expense1.31%1.38%0.76%0.73%0.73%Fee Waiver0.00%-0.98%-0.64%-0.50%-0.62%Net Expense1.31%1.05%0.63%0.62%0.60% Receive LMNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Defiance Daily Target 2X Long LMND ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LMNX ETF News HeadlinesDefiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Retractable Technologies (NYSE:RVP) Critical AnalysisMay 25 at 5:01 AM | americanbankingnews.comDefiance Launches XAIL, the World’s First 2X Leverage Pure Space ETFApril 8, 2026 | markets.businessinsider.comThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.May 25 at 1:00 AM | Behind the Markets (Ad)Defiance Daily Target 2X Long BTQ ETFJanuary 14, 2026 | money.usnews.comProCap is Proud to Announce the Planning Launch of the Luminex Payment GatewayNovember 14, 2024 | markets.businessinsider.comERS electronic GmbH: ERS electronic releases fully automatic Luminex machines with PhotoThermal debonding and wafer cleaning capabilityMay 29, 2024 | finanznachrichten.deSee More Headlines LMNX ETF - Frequently Asked Questions How have LMNX shares performed this year? Defiance Daily Target 2X Long LMND ETF's stock was trading at $29.7188 at the start of the year. Since then, LMNX shares have decreased by 55.8% and is now trading at $13.15. How were Defiance Daily Target 2X Long LMND ETF's earnings last quarter? Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) announced its quarterly earnings data on Sunday, February, 7th. The medical instruments supplier reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.12. Defiance Daily Target 2X Long LMND ETF's quarterly revenue was up 23.1% on a year-over-year basis. How do I buy shares of Defiance Daily Target 2X Long LMND ETF? Shares of LMNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Defiance Daily Target 2X Long LMND ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Defiance Daily Target 2X Long LMND ETF investors own include Bristol Myers Squibb (BMY), Intel (INTC), Micron Technology (MU), Cisco Systems (CSCO), NVIDIA (NVDA), Pfizer (PFE) and Qualcomm (QCOM). Fund Details IssuerDefiance ETFs Fund NameDefiance Daily Target 2X Long LMND ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:LMNX Inception Date10/15/2025 Fund ManagerStephen Foy Webwww.luminexcorp.com Phone512-219-8020Fund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings27 Fund Statistics Assets Under Management$6.32 million Average Daily Volume$0.00 Discount/Premium0.02% Leveraged2.00 Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorTidal Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares330,000Beta-12.97 Creation Fee$300.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Top 10 LMNX HoldingsUS DOLLARSHolding Weight: 63.93%Lemonade Inc Swap CsHolding Weight: 35.88%Lemonade Inc Swap Nomura-LHolding Weight: 35.28%Lemonade Inc Swap Jnst-LHolding Weight: 34.92%Lemonade Inc Swap MarexHolding Weight: 33.21%Lemonade Inc Swap CantorHolding Weight: 29.45%LEMONADE INC.-SWAP-NBCB-LHolding Weight: 20.20%United States Treasury Bills 0%Holding Weight: 11.42%First American Government Obligations FundHolding Weight: 6.79%OTHER ASSETS AND LIABILITIESHolding Weight: 3.39%Full Holdings Details This page (NASDAQ:LMNX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defiance Daily Target 2X Long LMND ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Defiance Daily Target 2X Long LMND ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
